Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Blocking Transmission Key In Malaria Fight

Devex: Block transmission Martin Edlund, CEO of Malaria No More “…[F]or malaria, the transit between mosquito and man isn’t just a joyride — it’s an essential step in reproduction. By blocking transmission, you isolate the mosquito and interrupt that process. … The classic approach to blocking transmission is to protect…

Research Continues To Develop Safe, Effective Ebola Vaccine

Media sources report on efforts to develop a vaccine to treat or prevent Ebola. CIDRAP News: At symposium, vaccine seen as best hope for arresting Ebola “At a wide-ranging symposium on West Africa’s Ebola epidemic [Tuesday], much of the attention focused on the hope of an effective vaccine, as a…

Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).

Researchers Target Mosquitoes In Fight Against Malaria

National Geographic: The War on Bugs “Faced with more than 600,000 deaths a year from malaria, scientists and their philanthropic backers have set their sights on the lowly mosquito. If we could annihilate mosquitoes, malaria would go, too, and with it dengue and other plagues. But simple extermination by DEET…

Canadian Ebola Vaccine Begins Human Trials

News outlets report on the start of clinical trials testing a Canadian Ebola vaccine. Agence France-Presse: Experimental Canadian Ebola vaccine starts human tests (10/13). Globe and Mail: As vaccine trials begin, Canada set to review Ebola strategy (Wingrove, 10/14). Reuters: Human testing begins on NewLink Genetics’ Ebola vaccine (Grover, 10/13).…

U.S. Officials Comment On Dallas Ebola Cases, Research Into Vaccines

News outlets report on U.S. health officials’ statements about the U.S. Ebola cases and research for a vaccine. Agence France-Presse: First U.S. Ebola infection result of ‘protocol breach’ “A Texas health care worker has become the first person to contract Ebola on American soil, authorities confirmed, blaming a safety breach…

First African Ebola Vaccine Trial Begins In Mali

News outlets report on the beginning of the first African Ebola vaccine trial. The Hill: Ebola vaccine trial begins in Africa “The first Ebola vaccine trial in Africa has started under the supervision of the University of Maryland, according to a report. Three health care workers in Mali received the…

Financial Times Publishes Special Report On Neglected Diseases

Financial Times: Special Report: Combating Neglected Diseases “While nobody questions the horror of the Ebola epidemic sweeping West Africa, the death toll — 3,500 and rising — is dwarfed by the number struck down each year by a range of less notorious infections…” The newspaper features several articles discussing several…

Ebola Raises Questions On Incentives For Drug, Vaccine Research

TIME: Ebola Should Change How We Fund Drugs for Emerging Disease “Emerging and infectious diseases are having a moment for all the worst reasons, with credit due to the Ebola outbreak. But scientists studying other emerging diseases beyond Ebola are hopeful that the attention on the disease — and what…